Alcon (ALC) Stock Forecast & Price Target

Q: What analysts cover Alcon?

Alcon has been rated by research analysts at Argus , BNP Paribas Exane , BTIG Research , Deutsche Bank Aktiengesellschaft , Jefferies Financial Group , JPMorgan Chase & Co. , Mizuho , Needham & Company LLC , and Weiss Ratings in the past 90 days.

$65.34 -0.25 (-0.38%)

Closing price 03:59 PM Eastern

Extended Trading

$65.32 -0.01 (-0.02%)

As of 07:30 PM Eastern

Compare

Alcon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
6

Buy
12

Based on 19 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 6 have given a hold rating, 11 have given a buy rating, and 1 has given a strong buy rating for ALC.

Consensus Price Target

$84.97
30.04% Upside

According to the 19 analysts' twelve-month price targets for Alcon, the average price target is $84.97. The highest price target for ALC is $101.09, while the lowest price target for ALC is $70.00. The average price target represents a forecasted upside of 30.04% from the current price of $65.34.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ALC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alcon and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALC Analyst Ratings Over Time

Type	Current Forecast 9/23/25 to 9/23/26	1 Month Ago 8/24/25 to 8/24/26	3 Months Ago 6/25/25 to 6/25/26	1 Year Ago 9/23/24 to 9/23/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	11 Buy rating(s)	11 Buy rating(s)	11 Buy rating(s)	9 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$84.97	$84.96	$85.12	$96.06
Forecasted Upside	30.04% Upside	15.31% Upside	25.20% Upside	27.73% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Alcon Stock vs. The Competition

Type	Alcon	Healthcare Companies	Broader Market
Consensus Rating Score	2.63	2.30	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	29.63% Upside	716.16% Upside	18.65% Upside
News Sentiment Rating	Neutral News See Recent ALC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/22/2026	Jefferies Financial Group 3 of 5 stars	Michael Sarcone Not Rated	Reiterated Rating	Buy	$85.00	+30.38%
9/15/2026	Needham & Company LLC 4 of 5 stars	David Saxon 2 of 5 stars	Reiterated Rating	Buy	$98.00	+44.73%
8/31/2026	Weiss Ratings 5 of 5 stars		Reiterated Rating	Hold (C-)
8/17/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
8/13/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$79.00	+7.38%
8/12/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Adlington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$77.53 ➝ $78.40	+8.56%
8/12/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$80.00 ➝ $85.00	+12.96%
8/11/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$82.00	+8.53%
7/2/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$85.00	+23.57%
5/8/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$90.00 ➝ $78.00	+22.11%
Get the Latest News and Ratings for ALC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.
5/7/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$97.00 ➝ $86.00	+33.31%
5/7/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$98.00 ➝ $90.00	+37.08%
5/6/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$70.00	+6.62%
1/30/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform
12/11/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Ouaddour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Underperform	$100.00 ➝ $75.00	-6.48%
12/10/2025	Oddo Bhf Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Outperform
11/28/2025	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
11/14/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Susannah Ludwig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$101.09	+28.47%
10/21/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Fishbin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$98.00 ➝ $91.00	+20.59%
10/13/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$91.00	+26.40%
8/26/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
8/21/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$84.00 ➝ $80.00	+1.40%
5/22/2025	Kepler Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	M. Pataki Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
3/25/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold
1/10/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Issie Kirby Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:37 PM ET.

Should I Buy Alcon Stock? ALC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 22, 2026. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

Alcon
Bull Case

Here are some ways that investors could benefit from investing in Alcon Inc.:

Alcon Inc. recently agreed to lower prescription drug prices for Americans as part of a White House deal with mid-sized pharmaceutical companies, which includes a commitment to a $19.6 billion infusion into US plants, potentially improving regulatory standing and domestic manufacturing presence.
The company reported Q2 2026 earnings that beat expectations, with sales rising 8 percent, and received a Buy rating from Berenberg, indicating strong fundamental performance and analyst confidence in its growth trajectory.
Alcon Inc. is expanding its eye care business in China, a key growth market, and completed Phase III patient enrollment for its Alcon-developed dry eye drug in China, signaling significant pipeline progress in a high-potential region.
The stock is currently trading at $65.57, which is near its 52-week low of $61.83, potentially offering a value entry point for investors given the company's recent earnings beat and strategic expansions.
Alcon Inc. launched the UNITY M ophthalmic microscope, a premium product delivering precise control, and its Clareon Monofocal IOL received EUMDR certification, demonstrating continued innovation and product pipeline strength in its Surgical segment.

Alcon
Bear Case

Investors should be bearish about investing in Alcon Inc. for these reasons:

Alcon Inc. faces intense competition and slowing cataract demand, as noted by SGA exiting the stock, which could pressure future revenue growth in its core Surgical segment.
The company's CEO stated that the US drug pricing deal may limit European products, creating potential regulatory and pricing headwinds that could impact global profitability and market access.
Alcon Inc. has a high P/E ratio of 50.06, which is significantly above the healthcare sector average, suggesting the stock may be overvalued relative to its earnings, especially with a 0.00% dividend yield offering no income cushion.
Short interest in Alcon Inc. has increased significantly, with shares shorted rising to 14.57 million as of August 31, 2026, and days to cover increasing to 12.57, indicating growing bearish sentiment among institutional investors.
Tariffs and intense competition remain key risks for Alcon Inc., as noted by Zacks, which could erode margins and limit the company's ability to maintain pricing power in key markets.

ALC Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $84.97, with a high forecast of $101.09 and a low forecast of $70.00.

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ALC shares.

According to analysts, Alcon's stock has a predicted upside of 30.04% based on their 12-month stock forecasts.

Over the previous 90 days, Alcon's stock had 1 downgrade by analysts.

Alcon has been rated by research analysts at Argus, BNP Paribas Exane, BTIG Research, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Needham & Company LLC, and Weiss Ratings in the past 90 days.

Analysts like Alcon more than other "healthcare" companies. The consensus rating for Alcon is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how ALC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Alcon Recommendations

MarketBeat monitors more than a dozen sources for Alcon analyst ratings, with the most recent rating issued on 9/22/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alcon (ALC) Stock Forecast & Price Target